Two types of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy

doi:10.12047/j.cjap.0096.2021.101

Abstract

Abstract: Objective: Insufcient exercise blood pressure response(blunted ABPR) and lower blood pressure during the recovery period (LBP)after exercise are common abnormalities in patients with hypertrophic cardiomyopathy (HCM). The purpose of this study was to analyze the related factors of these two types of abnormal blood pressure response in HCM patients and their relationship with cardiopulmonary function. Methods: A total of 219 consecutive HCM patients who underwent CPET in Fuwai hospital were recruited from April 1, 2018 to Jan 31, 2020 with a complete clinical assessment, including electrocardiography, HOLTER, rest echocardiography and cardiac MRI. One hundred and eleven healthy age- and gender-matched volunteers enrolled as control group. Results: The incidences of blunted ABPR and LBP in HCM patients were much higher than normal control group (8.7% vs 1.8%, P=0.016; 6.8% vs 0.0%, P=0.003, respectively). In HCM group, patients with blunted ABPR combined more coronary artery disease (CAD) (P=0.029), pulmonary hypertension (PH) (P=0.002) and atrial fibrillation/flutter (P=0.036) compared with patients without blunted ABPR. Compared with HCM patients without LBP, the patients with LBP had higher rest left ventricular outflow tract (LVOT) gradient (P=0.017) and left ventricular ejection fraction (P=0.043), more incidence of LVOT obstructive (P=0.015) and systolic anterior motion (P=0.022). After Logistic regression analysis, CAD and PH were independent factor of blunted ABPR, while LBP was only independently associated with rest LVOT gradient. Blunted ABPR was associated with lower Peak VO₂, peak heart rate and hear rate reserve, and higher NT-proBNP (P=0.019), VE/VO₂ (P=0.000). LBP was not associated with any index of cardiopulmonary function. Conclusion: The incidences of blunted ABPR and LBP in HCM patients were much higher than normal control group. In HCM patients, CAD and PH were independent determinants of blunted ABPR, while LBP was only independently associated with rest LVOT gradient. Patients with blunted ABPR had lower cardiopulmonary function, but LBP was not associated cardiopulmonary function.

Key words: exercise blood pressure response, hypertrophic cardiomyopathy, cardiopulmonary exercise testing, post exercise hypotension

CLC Number:

R542.2

HU Xiao-ying, SUN Xing-guo, QIAO Shu-bin, GAO Xiao-jin, LUO Xiao-liang, LIU Fang, ZHANG Ye, HAO Lu, SONG Ya, CHEN Ying-zhe, WANG Ji-nan, TAI Wen-qi, SHI Chao, XU Fan, ZHAI Wen-xuan, YANG Jie, ZHANG Tian-jing. Two types of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy[J]. CJAP, 2021, 37(1): 27-33.

References

[1] Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2014, 35(39): 2733-2779.
[2] O'Neal WT, Qureshi WT, Blaha MJ, et al. Systolic blood pressure response during exercise stress testing: The Henry Ford ExercIse Testing (FIT) Project[J]. J Am Heart Assoc, 2015, 4(5): e002050.
[3] Olivotto I, Maron B J, Montereggi A, et al. Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy[J]. J Am Coll Cardiol, 1999, 33(7): 2044-51.
[4] Nagata M, Shimizu M, Ino H, et al. Hemodynamic changes and prognosis in patients with hypertrophic cardiomyopathy and abnormal blood pressure responses during exercise[J]. Clin Cardiol, 2010, 26(2): 71-76.
[5] Counihan PJ, Frenneaux MP, Webb DJ, et al. Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy[J]. Circulation, 1991, 84(2): 686-696.
[6] Ciampi Q, Betocchi S, Lombardi R, et al. Hemodynamic determinants of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy[J]. J Am Coll Cardiol, 2002, 40(2): 278-284.
[7] Kim JJ, Lee CW, Park SW, et al. Improvement in exercise capacity and exercise blood pressure response after transcoronary alcohol ablation therapy of septal hypertrophy in hypertrophic cardiomyopathy[J]. Am J Cardiol, 1999, 83(8): 1220-1223.
[8] Yoshida N, Ikeda H, Wada T,et al. Exercise-induced abnormal blood pressure responses are related to subendocardial ischemia in hypertrophic cardiomyopathy[J]. J Am Coll Cardiol, 1998, 32(7): 1938-1942.
[9] 中华医学会心血管病学分会, 中国成人肥厚型心肌病诊断与治疗指南编写组, 中华心血管病杂志编辑委员会. 中国成人肥厚型心肌病诊断与治疗指南[J]. 中华心血管病杂志, 2017, 45(12): 1015-1032.
[10] 孙兴国, 胡大一. 心肺运动试验的实验室和设备要求及其临床实施难点的质量控制[J]. 中华心血管病杂志, 2014, 42(10): 817-821.
[11] Stringer BW, Hansen KE, Sun X.Oxygen uptake efficiency plateau best predicts early death in heart failure[J]. Chest, 2012, 141(5): 1284-1294.
[12] Fletcher GF, Ades PA, Kligfield P, et al. Exercise standards for testing and training: a scientific statement from the American Heart Association[J]. Circulation, 2013, 128(8): 873-934.
[13] Rowin EJ, Maron BJ, Olivotto I, et al. Role of exercise testing in hypertrophic cardiomyopathy[J]. JACC Cardiovasc Imaging, 2017, 10(11): 1374-1386.
[14] Frenneaux MP, Counihan PJ, Caforio AL, et al. Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy.[J]. Circulation, 1990, 82(6): 1995-2002.
[15] Smith ED, Tome J, Mcgrath R, et al. Exercise hemodynamics in hypertrophic cardiomyopathy identify risk of incident heart failure but not ventricular arrhythmias or sudden cardiac death[J]. Int J Cardiol, 2019, 274: 226-231.
[16] Hakki AH, Munley BM, Hadjimiltiades S, et al. Determinants of abnormal blood pressure response to exercise in coronary artery disease[J]. Am J Cardiol, 1986, 57(1): 71-75.
[17] Faure M, Valentin S, Zysman M, et al. Exercise hemodynamics in the prognosis of patients with pulmonary arterial hypertension[J]. Respiration, 2020, 99(8): 678-685.
[18] Coats CJ, Rantell K, Bartnik A, et al. Cardiopulmonary exercise testing and prognosis in hypertrophic cardiomyopathy[J]. Circ Heart Fail, 2015, 8(6): 1022-31.
[19] Finocchiaro G, Haddad F, Knowles JW, et al. Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy: a potential role for comprehensive noninvasive hemodynamic assessment[J]. JACC Heart Failure, 2015, 3(5): 408-418.